Chiesi to acquire rare disease company Zymenex

Chiesi Farmaceutici S.p.A. (Parma, Italy) will acquire rare disease company Zymenex A/S (Hillerod, Denmark) for an undisclosed amount. Chiesi will gain Zymenex's Lamazym, a recombinant human mannosida...